Evidence map›Paper›PMID 32456426›Full record

ArticleJournal of the American Chemical Society2020

Impact of Excited-State Antiaromaticity Relief in a Fundamental Benzene Photoreaction Leading to Substituted Bicyclo[3.1.0]hexenes.

Tomáš Slanina, Rabia Ayub, Josene Toldo, Johan Sundell, Wangchuk Rabten, Marco Nicaso, Igor Alabugin, Ignacio Fdez Galván, Arvind K Gupta, Roland Lindh and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of the American Chemical Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 61 citations in OpenAlex.

  1. Large Stokes shift fluorophores fromChemical science · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Aromaticity Reversal Induced by Vibrations in Cyclo[16]carbon.Journal of the American Chemical Society · 2023
    Article
  9. Review
  10. Article
  11. Article
  12. Baird's rules at the tipping point.Nature chemistry · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 3 countries.

Tomáš SlaninaDepartment of Chemistry - Ångström Laboratory, Uppsala University, SE-751 20, Uppsala, Sweden.ORCID 0000-0001-8092-7268
Rabia AyubDepartment of Chemistry - Ångström Laboratory, Uppsala University, SE-751 20, Uppsala, Sweden.ORCID 0000-0003-2128-6733
Josene ToldoDepartment of Chemistry - Ångström Laboratory, Uppsala University, SE-751 20, Uppsala, Sweden.ORCID 0000-0002-8969-6635
Johan SundellMedicinal Chemistry, Research and Early Development Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.ORCID 0000-0001-8579-9293
Wangchuk RabtenDepartment of Chemistry - Ångström Laboratory, Uppsala University, SE-751 20, Uppsala, Sweden.
Marco NicasoDepartment of Chemistry - Ångström Laboratory, Uppsala University, SE-751 20, Uppsala, Sweden.ORCID 0000-0003-0389-5041
Igor AlabuginDepartment of Chemistry and Biochemistry, Florida State University, Tallahassee, Florida 32306-4390, United States.ORCID 0000-0001-9289-3819
Ignacio Fdez GalvánDepartment of Chemistry - BMC, Uppsala University, SE-751 23 Uppsala, Sweden.ORCID 0000-0002-0684-7689
Arvind K GuptaDepartment of Chemistry - Ångström Laboratory, Uppsala University, SE-751 20, Uppsala, Sweden.ORCID 0000-0002-8969-1236
Roland LindhDepartment of Chemistry - BMC, Uppsala University, SE-751 23 Uppsala, Sweden.ORCID 0000-0001-7567-8295
Andreas OrthaberDepartment of Chemistry - Ångström Laboratory, Uppsala University, SE-751 20, Uppsala, Sweden.ORCID 0000-0001-5403-9902
Richard J LewisMedicinal Chemistry, Research and Early Development Respiratory, Inflammation and Autoimmune, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.ORCID 0000-0001-9404-8520
Gunnar GrönbergMedicinal Chemistry, Research and Early Development Respiratory, Inflammation and Autoimmune, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Joakim BergmanMedicinal Chemistry, Research and Early Development Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.ORCID 0000-0003-0413-1756
Henrik OttossonDepartment of Chemistry - Ångström Laboratory, Uppsala University, SE-751 20, Uppsala, Sweden.ORCID 0000-0001-8076-1165
Uppsala University · SEAstraZeneca (Sweden) · SEFlorida State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Benzene exhibits a rich photochemistry which can provide access to complex molecular scaffolds that are difficult to access with reactions in the electronic ground state. While benzene is aromatic in its ground state, it is antiaromatic in its lowest ππ* excited states. Herein, we clarify to what extent relief of excited-state antiaromaticity (ESAA) triggers a fundamental benzene photoreaction: the photoinitiated nucleophilic addition of solvent to benzene in acidic media leading to substituted bicyclo[3.1.0]hex-2-enes. The reaction scope was probed experimentally, and it was found that silyl-substituted benzenes provide the most rapid access to bicyclo[3.1.0]hexene derivatives, formed as single isomers with three stereogenic centers in yields up to 75% in one step. Two major mechanism hypotheses, both involving ESAA relief, were explored through quantum chemical calculations and experiments. The first mechanism involves protonation of excited-state benzene and subsequent rearrangement to bicyclo[3.1.0]hexenium cation, trapped by a nucleophile, while the second involves photorearrangement of benzene to benzvalene followed by protonation and nucleophilic addition. Our studies reveal that the second mechanism is operative. We also clarify that similar ESAA relief leads to puckering of S

Identifiers

PMID32456426
PMCPMC7497645
OpenAlexW3028816074

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.